Gene signature for response prediction to immunotherapy and prognostic markers in metastatic urothelial carcinoma.

Front Immunol · 2025 · PMC12675356 · PMID 41357226

Europe PMC DOI

hedged sentence

0.0000

closest p · 0.0× alpha

0.0000

boldest claim

The sentences

highly significantP < 2 × 10 -11actually significant

PD comparisons were highly significant (P < 2 × 10 -11 ).

also in 132,142 other papers

Quoted from the open-access full text in Europe PMC under the licence the publisher applied. The sentence is reproduced exactly as published; the emphasis is ours.